These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6389394)

  • 1. Antimicrobial therapy of chronic otitis media with effusion.
    Healy GB
    Int J Pediatr Otorhinolaryngol; 1984 Oct; 8(1):13-7. PubMed ID: 6389394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of cotrimoxazole therapy in serous otitis media.
    Marks NJ; Mills RP; Shaheen OH
    J Laryngol Otol; 1981 Oct; 95(10):1003-9. PubMed ID: 7028896
    [No Abstract]   [Full Text] [Related]  

  • 3. Cotrimoxazole in the treatment of serous otitis. A follow-up report.
    Marks NJ; Mills RP; Shaheen OH
    J Laryngol Otol; 1983 Mar; 97(3):213-5. PubMed ID: 6339654
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group.
    Barnett ED; Teele DW; Klein JO; Cabral HJ; Kharasch SJ
    Pediatrics; 1997 Jan; 99(1):23-8. PubMed ID: 8989332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroral prednisolone in the treatment of middle-ear effusion in children: a double-blind study.
    Puhakka H; Haapaniemi J; Tuohimaa P; Ruuskanen O; Eskola J
    Auris Nasus Larynx; 1985; 12 Suppl 1():S268-71. PubMed ID: 3915207
    [No Abstract]   [Full Text] [Related]  

  • 6. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.
    Krause PJ; Owens NJ; Nightingale CH; Klimek JJ; Lehmann WB; Quintiliani R
    J Infect Dis; 1982 Jun; 145(6):815-21. PubMed ID: 7200999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media.
    Marchant CD; Shurin PA; Turcyzk VA; Feinstein JC; Johnson CE; Wasikowski DE; Knapp LJ; Tutihasi MA
    J Pediatr; 1984 Oct; 105(4):633-8. PubMed ID: 6384453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media.
    Klimek JJ; Bates TR; Nightingale C; Lehmann WB; Ziemniak JA; Quintiliani R
    J Pediatr; 1980 Jun; 96(6):1087-9. PubMed ID: 7189554
    [No Abstract]   [Full Text] [Related]  

  • 9. Developments in diagnosing and treating otitis media.
    Eichenwald H
    Am Fam Physician; 1985 Mar; 31(3):155-64. PubMed ID: 3872049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial therapy for acute otitis media: a critical analysis.
    Marchant C; Shurin PA
    Rev Infect Dis; 1982; 4(2):506-13. PubMed ID: 7051243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cefaclor and trimethoprim-sulfamethoxazole in the treatment of acute otitis media.
    Blumer JL; Bertino JS; Husak MP
    Pediatr Infect Dis; 1984; 3(1):25-9. PubMed ID: 6366771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim-sulfamethoxazole v. amoxicillin in the treatment of acute otitis media.
    Feldman W; Momy J; Dulberg C
    CMAJ; 1988 Nov; 139(10):961-4. PubMed ID: 3052769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion ("secretory" otitis media) in children. Results of a double-blind, randomized trial.
    Cantekin EI; Mandel EM; Bluestone CD; Rockette HE; Paradise JL; Stool SE; Fria TJ; Rogers KD
    N Engl J Med; 1983 Feb; 308(6):297-301. PubMed ID: 6337322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole.
    Rubin RH; Swartz MN
    N Engl J Med; 1980 Aug; 303(8):426-32. PubMed ID: 6967184
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative efficacy of ampicillin and trimethoprim-sulfamethoxazole in otitis media.
    Cameron GG; Pomahac AC; Johnston MT
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):87-8. PubMed ID: 1093657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of chronic middle-ear effusion. Results of a clinical trial of prednisone combined with sulfamethoxazole and trimethoprim.
    Berman S; Grose K; Zerbe GO
    Am J Dis Child; 1987 Jun; 141(6):690-4. PubMed ID: 3554985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of recurrent acute otitis media and middle-ear effusion. Comparison of amoxicillin with sulfamethoxazole and trimethoprim.
    Principi N; Marchisio P; Massironi E; Grasso RM; Filiberti G
    Am J Dis Child; 1989 Dec; 143(12):1414-8. PubMed ID: 2589274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae.
    Schwartz RH; Rodriguez WJ; Khan WN; Mann R; Barsanti RG; Ross S
    Rev Infect Dis; 1982; 4(2):514-6. PubMed ID: 6981169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial comparing three treatments for chronic otitis media with effusion.
    Giebink GS; Batalden PB; Le CT; Lassman FM; Buran DJ; Seltz AE
    Pediatr Infect Dis J; 1990 Jan; 9(1):33-40. PubMed ID: 2405348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment of secretory otitis media assessed by impedence audiometry.
    Goodey RJ; Bowers M
    N Z Med J; 1975 Sep; 82(548):187-8. PubMed ID: 812030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.